HIV treatment and prevention on every 2026 South Carolina Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 11 stand-alone Part D plans in South Carolina cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
11 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | Wellcare Value Script$4.80/moS4802-144 | Wellcare Classic$9.70/moS4802-070 | Humana Basic Rx Plan$10.10/moS5884-134 | Humana Value Rx Plan$65.60/moS5884-188 | HealthSpring Extra Rx$71.20/moS5617-359 | SilverScript Choice$98.40/moS5601-018 | AARP Medicare Rx Saver from UHC$122.10/moS5921-354 | AARP Medicare Rx Preferred from UHC$139.20/moS5921-391 | BlueCross Rx Value$139.70/moS5953-001 | Humana Premier Rx Plan$145.60/moS5884-155 | HealthSpring Assurance Rx$152.50/moS5617-218 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biktarvybictegravir/emtricitabine/tenofovir alafenamide | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 531%QL 30/30d | Tier 525%QL 30/30d | Tier 533%QL 30/30d | Tier 525% |
| Dovatodolutegravir and lamivudine | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 531%QL 30/30d | Tier 525%QL 30/30d | Tier 533%QL 30/30d | Tier 525% |
| Triumeqabacavir/dolutegravir/lamivudine | Tier 440% | Tier 427% | Tier 430%QL 180/30d | Tier 434%QL 180/30d | Tier 430%QL 300/30d | Tier 433% | Tier 436%QL 180/30d | Tier 435%QL 180/30d | Tier 450%QL 180/30d | Tier 450%QL 180/30d | Tier 431%QL 300/30d |
| Genvoyaelvitegravir/cobicistat/emtricitabine/tenofovir alafenamide | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525%QL 30/30d | Tier 531%QL 30/30d | Tier 525%QL 30/30d | Tier 533%QL 30/30d | Tier 525%QL 30/30d |
| Odefseyemtricitabine/rilpivirine/tenofovir alafenamide | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525%QL 30/30d | Tier 531%QL 30/30d | Tier 525%QL 30/30d | Tier 533%QL 30/30d | Tier 525%QL 30/30d |
| Symtuzadarunavir/cobicistat/emtricitabine/tenofovir alafenamide | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 531%QL 30/30d | Tier 525%QL 30/30d | Tier 533%QL 30/30d | Tier 525% |
| Julucadolutegravir and rilpivirine | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 531%QL 30/30d | Tier 525%QL 30/30d | Tier 533%QL 30/30d | Tier 525% |
| Descovyemtricitabine and tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525%QL 30/30d | Tier 531%QL 30/30d | Tier 525%QL 30/30d | Tier 533%QL 30/30d | Tier 525%QL 30/30d |
| Truvadaemtricitabine and tenofovir disoproxil | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| emtricitabine-tenofovirgeneric Truvada | Tier 440%QL 30/30d | Tier 427%QL 30/30d | Tier 430%QL 30/30d | Tier 434%QL 30/30d | Tier 430%QL 30/30d | Tier 433%QL 30/30d | Tier 436%QL 30/30d | Tier 435%QL 30/30d | Tier 2$17.00QL 30/30d | Tier 450%QL 30/30d | Tier 431%QL 30/30d |
| Tivicaydolutegravir | Tier 525% | Tier 525% | Tier 525%QL 60/30d | Tier 526%QL 60/30d | Tier 430%QL 180/30d | Tier 525% | Tier 525%QL 60/30d | Tier 531%QL 60/30d | Tier 450%QL 180/30d | Tier 533%QL 60/30d | Tier 431%QL 180/30d |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.